RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

SWAN Capital LLC's Holding History (CIK: 0001952722)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 50 Value ($000) $0 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 115 Value ($000) $1 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 115 Value ($000) $1 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 115 Value ($000) $1 Avg Close $6.72 Range $5.60 - $9.55